期刊文献+

骨化三醇注射液冲击治疗尿毒症继发性甲状旁腺功能亢进的临床疗效观察 被引量:6

下载PDF
导出
摘要 目的探讨对尿毒症继发性甲状旁腺功能亢进患者采用骨化三醇注射液冲击治疗的临床效果。方法 60例尿毒症继发性甲状旁腺功能亢进患者,采用随机数字表法分为A1组和A2组,各30例。A2组采用常规剂量骨化三醇治疗,A1组采用骨化三醇冲击治疗。观察对比临床疗效及相关指标水平。结果 A1组治疗总有效率明显高于A2组,差异有统计学意义(P<0.05);A1组甲状旁腺激素(PTH)、磷(P)水平明显低于A2组,钙(Ca)水平明显高于A2组,差异均有统计学意义(P<0.05)。结论临床对尿毒症继发性甲状旁腺功能亢进患者治疗过程中,开展骨化三醇治疗,患者不会出现严重的不良反应,体现出较高的安全性以及有效性。
出处 《中国现代药物应用》 2016年第9期140-141,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献5

二级参考文献31

  • 1张拔山,林宏初,曾龙宏,赖福娣.慢性肾衰继发性甲旁亢iPTH水平变化的临床意义及罗钙全疗效观察[J].国际医药卫生导报,2004,10(18):38-40. 被引量:5
  • 2王红鹰,邹强,周坚,劳正胤,薛骏,李铭新,李海明,顾勇,张延龄.慢性肾功能衰竭继发甲状旁腺功能亢进的外科治疗[J].外科理论与实践,2005,10(6):522-524. 被引量:4
  • 3李海明,顾勇,薛骏,李铭新,陈靖,陆福明,王红鹰,邹强.甲状旁腺全切除加前臂移植治疗尿毒症继发性甲状旁腺功能亢进[J].中华肾脏病杂志,2006,22(4):197-200. 被引量:40
  • 4Kidney Disease Outcomes Quality Initiative (K/DOQI). K/ DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease [J]. Am J Kidney Dis, 2003,42( 1 ) : S1-201.
  • 5Blacher J, Guerin A P, Pannier B, et al. Arterial calcifications,arterial stiffness, and cardiovascular risk in end-stage renal disease [J]. Hypertension, 2001,38(4) :938-942.
  • 6Rocco M V, Yah G, Gassman J, et al. Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration [J]. Am J Kidney Dis, 2002,39(1) : 146-153.
  • 7Yoshihiro T, Susumu M, Tetsuhiko S. Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease [J]. Ther Apher Dial, 2005,9( 1 ) : 44-47.
  • 8Malberti F. Management of hyperphosphatemia in dialysis patients: the role of phosphate binders [J]. G Ital Nefrol, 2010, 27(Suppl 52): 47-54.
  • 9Ishida M, Yao N, Yachiku S, et al. Management of calcium, phos- phorus and bone metalbolian in dialysis patients using sevelamer hy- drochloride and vitamin D therapy [J]. Ther Apher Dial, 2005, 9 (Suppl 1): 16-21.
  • 10Spaia S. Phosphate binders: Scvciamcr in the prevention and treat- ment of hyperphosphataemia in chronic renal failure [Jr]. Hippokra- tia, 2011, 15(Suppl 1): 22-26.

共引文献78

同被引文献54

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部